Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences balance Sheet — Total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (DB)
Latest, Q2 2026
49,362
Period ended Jun 30, 2026
Change on a year earlier
-11.4%
55,721 in Q2 2025
History
69 quarters
Since Q4 2008
Sources
66
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Balance Sheet — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 49,362 | -11.4% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 56,278 | -0.3% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 59,023 | 0.0% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 58,533 | +7.4% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 55,721 | +4.0% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 56,434 | +0.3% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 58,995 | -5.0% | Form 10-K (filed 2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 54,525 | -12.6% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 53,579 | -14.0% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 56,292 | -9.0% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 62,125 | -1.7% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 62,373 | -0.3% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 62,337 | -0.8% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 61,876 | -1.9% | Form 10-Q (filed 2023-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 63,171 | -7.0% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 62,557 | -6.8% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 62,870 | -7.5% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 63,080 | -6.5% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 67,952 | -0.7% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 67,098 | +10.2% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 67,984 | +21.5% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 67,492 | +13.0% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 68,407 | +11.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 60,878 | +2.9% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 55,934 | -11.5% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 59,741 | -4.9% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 61,627 | -3.2% | Form 10-K (filed 2020-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 59,146 | -8.0% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 63,210 | -3.3% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 62,837 | -3.9% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 63,675 | -9.4% | Form 10-K (filed 2019-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 64,305 | -0.6% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 65,355 | +8.4% | Form 10-Q (filed 2018-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 65,381 | +13.3% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 70,283 | +23.4% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 64,662 | +14.2% | Form 10-Q (filed 2017-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 60,263 | +20.6% | Form 10-Q (filed 2017-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 57,701 | +20.8% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 56,977 | +10.2% | Form 10-K (filed 2017-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 56,609 | +11.8% | Form 10-Q (filed 2016-11-07) ↗ |
| Q2 2016 | Jun 30, 2016 | 49,980 | +27.6% | Form 10-Q (filed 2016-08-05) ↗ |
| Q1 2016 | Mar 31, 2016 | 47,765 | +24.6% | Form 10-Q (filed 2016-05-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 51,716 | +49.2% | Form 10-Q (filed 2016-05-06) ↗ |
| Q3 2015 | Sep 30, 2015 | 50,637 | +75.6% | Form 10-Q (filed 2015-11-04) ↗ |
| Q2 2015 | Jun 30, 2015 | 39,167 | +25.5% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 38,321 | +36.5% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 34,664 | +53.5% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2014 | Sep 30, 2014 | 28,844 | +28.4% | SEC Filing ↗ |
| Q2 2014 | Jun 30, 2014 | 31,206 | +37.9% | SEC Filing ↗ |
| Q1 2014 | Mar 31, 2014 | 28,078 | +26.4% | SEC Filing ↗ |
| Q4 2013 | Dec 31, 2013 | 22,579 | +6.3% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2013 | Sep 30, 2013 | 22,468 | +7.2% | Form 10-Q (filed 2013-10-31) ↗ |
| Q2 2013 | Jun 30, 2013 | 22,624 | +10.4% | Form 10-Q (filed 2013-08-01) ↗ |
| Q1 2013 | Mar 31, 2013 | 22,212 | +11.3% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 21,240 | +22.8% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 20,964 | +65.9% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 20,502 | +61.5% | Form 10-Q (filed 2012-08-01) ↗ |
| Q1 2012 | Mar 31, 2012 | 19,950 | +53.6% | Form 10-Q (filed 2012-05-04) ↗ |
| Q4 2011 | Dec 31, 2011 | 17,303 | +49.3% | Form 10-K (filed 2012-02-23) ↗ |
| Q3 2011 | Sep 30, 2011 | 12,640 | +10.3% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 12,694 | – | Form 10-Q (filed 2011-08-05) ↗ |
| Q1 2011 | Mar 31, 2011 | 12,987 | +21.4% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2010 | Dec 31, 2010 | 11,593 | +19.5% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 11,456 | +28.2% | Form 10-Q (filed 2010-11-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 10,696 | – | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2009 | Dec 31, 2009 | 9,699 | +39.8% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 8,937 | – | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 30, 2009 | 8,387 | – | Form 10-Q (filed 2009-08-05) ↗ |
| Q4 2008 | Dec 31, 2008 | 6,937 | – | Form 10-Q (filed 2009-08-05) ↗ |
Breakdown
What makes up balance sheet — total assets ($m)
- Accounts receivable, net ($M)5,055 · Q2 2026
- Inventories ($M)1,953 · Q2 2026
- Total current assets ($M)13,945 · Q2 2026
- Property, plant and equipment, net ($M)5,833 · Q2 2026
- Goodwill ($M)8,314 · Q2 2026
- Intangible assets, net ($M)14,032 · Q2 2026
- Total current liabilities ($M)11,020 · Q2 2026
- Long-term debt, noncurrent ($M)23,832 · Q2 2026
- Retained earnings ($M)2,200 · Q2 2026
- Total stockholders' equity ($M)11,744 · Q2 2026
Cite this data
StockData. (2026). Gilead Sciences Balance Sheet — Total assets ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_balance_sheet
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.